Steven L. Krill

Biography

Dr. Krill has served as Eagle Pharmaceuticals’ chief scientific officer since February 2013. Before that, he held the position of vice president of pharmaceutical development from October 2011 to February 2013. Prior to joining Eagle Pharmaceuticals, Dr. Krill served as the vice president of scientific affairs at Teva Parenteral Medicines. A few years prior, at Boehringer Ingelheim, Dr. Krill was vice president, pharmaceutical research and development (December 2005 to March 2009) and director of pharmaceutics and investigational supplies (May 2002 to December 2005). He has also held various management positions at Lipocine Inc., Novartis Pharmaceuticals, and Abbott Laboratories. Dr. Krill is an author of over 30 publications and inventor of multiple patents in the area of drug delivery. He holds a BS in pharmacy and an MS in pharmaceutical sciences from the University of Cincinnati and a PhD in Pharmaceutics from the University of Utah.

Research Interest

 Pharmaceutical Science